4.7 Article

Functional TCR T cell screening using single-cell droplet microfluidics

Journal

LAB ON A CHIP
Volume 18, Issue 24, Pages 3733-3749

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c8lc00818c

Keywords

-

Funding

  1. NIH [1DP2CA195763, R21CA219225]
  2. Amberstone Biosciences LLC [AB-208317]
  3. NATIONAL CANCER INSTITUTE [R21CA219225, DP2CA195763] Funding Source: NIH RePORTER
  4. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Adoptive T cell transfer, in particular TCR T cell therapy, holds great promise for cancer immunotherapy with encouraging clinical results. However, finding the right TCR T cell clone is a tedious, time-consuming, and costly process. Thus, there is a critical need for single cell technologies to conduct fast and multiplexed functional analyses followed by recovery of the clone of interest. Here, we use droplet microfluidics for functional screening and real-time monitoring of single TCR T cell activation upon recognition of target tumor cells. Notably, our platform includes a tracking system for each clone as well as a sorting procedure with 100% specificity validated by downstream single cell reverse-transcription PCR and sequencing of TCR chains. Our TCR screening prototype will facilitate immunotherapeutic screening and development of T cell therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available